USANA Health Sciences (USNA)
Makes supplements and kids wellness products across direct-selling and direct-to-consumer channels.
Something off on this page? Send us feedback.
Sells nutritional supplements, foods, skincare, and personal-care products through a direct-selling core, plus Hiya kids wellness through direct-to-consumer subscriptions. The business is weighted toward Asia Pacific and depends on Brand Partner retention, product compliance, China regulation, and the newer omni-channel mix.
Develops and manufactures science-based nutritional supplements, functional foods, personal-care products, and skincare under the Core nutritional segment. Hiya adds a U.S. children's health-and-wellness line built around direct-to-consumer subscriptions, with Rise adding protein-bar exposure outside the legacy channel.
Core nutritional is sold mainly through Brand Partners and Preferred Customers, while the broader platform now spans direct selling, direct-to-consumer, marketplace, and retail channels. Asia Pacific is the largest regional weight, with the Americas and Europe forming the other disclosed region.
Execution centers on formulation, in-house manufacturing, customer education, and compensation-plan management. The business depends on Brand Partner retention, China and other direct-selling rules, dietary-supplement and food compliance, and reputation in nutrition and direct selling.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
No analyst notes in the last 24 months.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jul 4, 2026Cash & short-term investments $168.6M · Total debt $0 · Total assets $703.2M · Shareholders' equity $526.3M
- Revenue
- $223.3M
- Operating income
- −$20.0M
- Net income
- −$21.4M
No dividends on record.
| Institutions | 63.15% | 11.66M shares | |
|---|---|---|---|
| 140 holders · as of Jun 30, 2026 | |||
| Insiders | 0.75% | 138.7K shares | |
| 13 holders · as of Jul 27, 2026 | |||
| Other | 36.10% | 6.67M shares | |
| remainder | |||
18.46M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 8.42% | 1.55M | as of Jun 30, 2026 |
Pzena Investment Management LLCInstitution | 6.53% | 1.21M | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 5.19% | 958,520 | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 4.54% | 837,426 | as of Jun 30, 2026 |
Nantahala Capital Management, LLCInstitution | 4.39% | 810,074 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 16, 2026 | Brent Neidig | officer: CHIEF COMMERCIAL OFFICER | −5,002 | $19.45 |
| Jun 15, 2026 | Brent Neidig | officer: CHIEF COMMERCIAL OFFICER | −909 | $20.01 |
| Jun 12, 2026 | Brent Neidig | officer: CHIEF COMMERCIAL OFFICER | −1,602 | $20.15 |
| Jun 8, 2026 | Paul A. Jones | officer: CHIEF PEOPLE OFFICER | −5,561 | $18.50 |
| Jun 1, 2026 | John Turman Fleming | director | −2,450 | $17.93 |
- Herbalife
Global nutrition direct seller with large distributor overlap
- Nu Skin
Beauty and wellness direct seller competing in Asia-heavy markets
- Medifast
Coach-guided weight management and nutrition competitor
- Nature's Sunshine Products
Herbal and nutritional supplement direct seller
- LifeVantage
Science-positioned supplements sold through direct sales
- Mannatech
Smaller wellness direct seller with supplement and skin-care overlap
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| USANA Health Sciences | $14.76 | +1.86% | $267.5M | — | 14.5 | 0.3 | −5.3% |
| Herbalife | $12.05 | +1.05% | $1.24B | 7.7 | 4.5 | 0.2 | +5.4% |
| Nu Skin | $4.78 | +2.03% | $227.2M | — | 5.0 | 0.2 | −17.1% |
| Medifast | $12.19 | −0.57% | $136.3M | — | — | 0.4 | −27.6% |
| Nature's Sunshine Products | $13.16 | +1.08% | $229.0M | 12.9 | 12.2 | 0.5 | +2.0% |
| LifeVantage | $6.25 | +0.55% | $78.5M | 15.5 | 21.6 | 0.4 | −23.1% |
| Mannatech | $8.00 | −1.84% | $15.7M | — | — | 0.1 | +3.8% |
| Median | 12.9 | 8.6 | 0.3 | −7.6% |